In fact, while studies on oesophageal cancer correlate RKIP hyper-methylation with lower tumour differentiation, the acquisition of a metastatic phenotype, and an overall reduction of patient survival, it does not seem to predict patients’ survival in breast cancer cohorts. This evidence concerns the gene PEBP1 and breast carcinoma.